{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:34:05Z","timestamp":1791902045355,"version":"4.3.4"},"reference-count":45,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,5,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hematologic malignancies are a heterogeneous group of conditions with an unclear etiology. We hypothesized that diabetes mellitus type 2 is associated with increased risk of developing lymphoma, leukemia, and myeloma. A literature search identified 26 studies (13 case-control and 13 cohort studies) evaluating such an association. Outcome was calculated as the odds ratio (OR) using a random effects model. Heterogeneity and publication bias were evaluated using the I2 index and the trim-and-fill analysis, respectively. Quality was assessed using the Newcastle-Ottawa scale. The OR for non-Hodgkin lymphoma was increased at 1.22 (95% confidence interval [CI], 1.07-1.39; P &lt; .01) but the OR for Hodgkin lymphoma was not. There was an increased OR for peripheral T-cell lymphoma (OR = 2.42, 95% CI, 1.24-4.72; P = .009) but not for other non-Hodgkin lymphoma subtypes. The OR for leukemia was 1.22 (95% CI, 1.03-1.44; P = .02) and the OR for myeloma was 1.22 (95% CI, 0.98-1.53; P = .08). Although diabetes mellitus type 2 seems to increase the risk of developing lymphoma, leukemia, and myeloma, future studies should focus on evaluating other potential confounders such as obesity, dietary habits, physical activity, and\/or antidiabetic therapy.<\/jats:p>","DOI":"10.1182\/blood-2011-06-362830","type":"journal-article","created":{"date-parts":[[2012,4,10]],"date-time":"2012-04-10T23:24:27Z","timestamp":1334100267000},"page":"4845-4850","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":183,"title":["Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies"],"prefix":"10.1182","volume":"119","author":[{"given":"Jorge J.","family":"Castillo","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Rhode Island Hospital\/The Miriam Hospital, The Warren Alpert Medical School of Brown University, Providence, RI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Mull","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Miriam Hospital, The Warren Alpert Medical School of Brown University, Providence, RI; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Reagan","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Rhode Island Hospital\/The Miriam Hospital, The Warren Alpert Medical School of Brown University, Providence, RI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saed","family":"Nemr","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Miriam Hospital, The Warren Alpert Medical School of Brown University, Providence, RI; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Mitri","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Tufts University Medical School, Tufts Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111808105356100_B1","unstructured":"Surveillance Epidemiology and End Results\n          Accessed January 31, 2012\n          Available from: http:\/\/seer.cancer.gov\/statfacts\/index.html"},{"key":"2019111808105356100_B2","unstructured":"National Diabetes Information Clearinghouse\n          Accessed January 31, 2012\n          Available from: http:\/\/diabetes.niddk.nih.gov\/dm\/pubs\/statistics\/index.htm"},{"issue":"12","key":"2019111808105356100_B3","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.2337\/dc08-1034","article-title":"Diabetes and risk of non-Hodgkin's lymphoma: a meta-analysis of observational studies.","volume":"31","author":"Mitri","year":"2008","journal-title":"Diabetes Care"},{"issue":"15","key":"2019111808105356100_B4","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"2019111808105356100_B5","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.\n          Accessed January 31, 2012\n          Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"issue":"19","key":"2019111808105356100_B6","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","article-title":"What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes.","volume":"280","author":"Zhang","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"2019111808105356100_B7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"11","key":"2019111808105356100_B8","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"2","key":"2019111808105356100_B9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis.","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"issue":"3","key":"2019111808105356100_B10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ijc.25362","article-title":"Risk of cancer in a large cohort of U.S. veterans with diabetes.","volume":"128","author":"Atchison","year":"2011","journal-title":"Int J Cancer"},{"issue":"4","key":"2019111808105356100_B11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/jnci\/89.4.314","article-title":"Medical history risk factors for non-Hodgkin's lymphoma in older women.","volume":"89","author":"Cerhan","year":"1997","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2019111808105356100_B12","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/ijc.24456","article-title":"Common immune-related risk factors and incident non-Hodgkin lymphoma: the multiethnic cohort.","volume":"125","author":"Erber","year":"2009","journal-title":"Int J Cancer"},{"issue":"6","key":"2019111808105356100_B13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1634\/theoncologist.2009-0300","article-title":"Risk of cancer following hospitalization for type 2 diabetes.","volume":"15","author":"Hemminki","year":"2010","journal-title":"Oncologist"},{"issue":"6","key":"2019111808105356100_B14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2796.1997.tb00004.x","article-title":"Cancer and diabetes\u2013a follow-up study of two population-based cohorts of diabetic patients.","volume":"241","author":"Hjalgrim","year":"1997","journal-title":"J Intern Med"},{"issue":"2","key":"2019111808105356100_B15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.293.2.194","article-title":"Fasting serum glucose level and cancer risk in Korean men and women.","volume":"293","author":"Jee","year":"2005","journal-title":"JAMA"},{"issue":"6","key":"2019111808105356100_B16","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3324\/haematol.12297","article-title":"Diabetes and the risk of non-Hodgkin's lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition.","volume":"93","author":"Khan","year":"2008","journal-title":"Haematologica"},{"issue":"2","key":"2019111808105356100_B17","first-page":"253","article-title":"Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study.","volume":"7","author":"Khan","year":"2006","journal-title":"Asian Pac J Cancer Prev"},{"issue":"7","key":"2019111808105356100_B18","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/sj.bjc.6605240","article-title":"A cohort study of the risk of cancer associated with type 2 diabetes.","volume":"101","author":"Ogunleye","year":"2009","journal-title":"Br J Cancer"},{"issue":"1","key":"2019111808105356100_B19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0021-9681(82)90025-X","article-title":"Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus.","volume":"35","author":"Ragozzino","year":"1982","journal-title":"J Chronic Dis"},{"issue":"11","key":"2019111808105356100_B20","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/sj.bjc.6602611","article-title":"Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study.","volume":"92","author":"Swerdlow","year":"2005","journal-title":"Br J Cancer"},{"issue":"11","key":"2019111808105356100_B21","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/jnci\/89.11.816","article-title":"Medical history risk factors for non-Hodgkin's lymphoma in older women.","volume":"89","author":"Weiderpass","year":"1997","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"2019111808105356100_B22","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/jnci\/89.18.1360","article-title":"Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark.","volume":"89","author":"Wideroff","year":"1997","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2019111808105356100_B23","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ijc.2910430404","article-title":"A case-control study of multiple myeloma nested in the American Cancer Society prospective study.","volume":"43","author":"Boffetta","year":"1989","journal-title":"Int J Cancer"},{"issue":"1","key":"2019111808105356100_B24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/bjc.1987.158","article-title":"Chronic lymphocytic leukaemia: case control epidemiological study in Yorkshire.","volume":"56","author":"Cartwright","year":"1987","journal-title":"Br J Cancer"},{"issue":"1","key":"2019111808105356100_B25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0145-2126(98)80012-X","article-title":"Non-Hodgkin's lymphoma: case control epidemiological study in Yorkshire.","volume":"12","author":"Cartwright","year":"1988","journal-title":"Leuk Res"},{"issue":"10","key":"2019111808105356100_B26","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s10552-005-0358-7","article-title":"Anthropometrics, physical activity, related medical conditions, and the risk of non-Hodgkin lymphoma.","volume":"16","author":"Cerhan","year":"2005","journal-title":"Cancer Causes Control"},{"issue":"12","key":"2019111808105356100_B27","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.ejca.2005.04.032","article-title":"Type 2 diabetes mellitus, its treatment and risk for lymphoma.","volume":"41","author":"Fortuny","year":"2005","journal-title":"Eur J Cancer"},{"issue":"4","key":"2019111808105356100_B28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/aje\/kwg145","article-title":"Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco.","volume":"158","author":"Holly","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"1","key":"2019111808105356100_B29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.cej.0000228404.37858.40","article-title":"Diabetes and cancer risk for all and specific sites among Japanese men and women.","volume":"16","author":"Kuriki","year":"2007","journal-title":"Eur J Cancer Prev"},{"issue":"5","key":"2019111808105356100_B30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.cej.0000236253.93984.8f","article-title":"Diabetes mellitus associated with the occurrence and prognosis of non-Hodgkin's lymphoma.","volume":"16","author":"Lin","year":"2007","journal-title":"Eur J Cancer Prev"},{"issue":"8","key":"2019111808105356100_B31","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/ijc.21600","article-title":"Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada.","volume":"118","author":"Rousseau","year":"2006","journal-title":"Int J Cancer"},{"issue":"1","key":"2019111808105356100_B32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/030089160709300101","article-title":"Diabetes and risk of non-Hodgkin lymphoma: a case-control study.","volume":"93","author":"Scotti","year":"2007","journal-title":"Tumori"},{"issue":"6","key":"2019111808105356100_B33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/jech.54.6.431","article-title":"Haematopoietic cancer and medical history: a multicentre case control study.","volume":"54","author":"Vineis","year":"2000","journal-title":"J Epidemiol Community Health"},{"issue":"3","key":"2019111808105356100_B34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00125-010-1987-2","article-title":"Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies.","volume":"54","author":"Wotton","year":"2011","journal-title":"Diabetologia"},{"issue":"6985","key":"2019111808105356100_B35","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/bmj.310.6985.1009c","article-title":"Non-insulin dependent diabetes mellitus and non-Hodgkin's lymphoma. Other American studies fail to confirm an association.","volume":"310","author":"Zahm","year":"1995","journal-title":"BMJ"},{"issue":"4","key":"2019111808105356100_B36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3322\/caac.20078","article-title":"Diabetes and cancer: a consensus report.","volume":"60","author":"Giovannucci","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"9612","key":"2019111808105356100_B37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"2019111808105356100_B38","first-page":"187","article-title":"Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections.","volume":"18","author":"Moutschen","year":"1992","journal-title":"Diabete Metab"},{"issue":"4","key":"2019111808105356100_B39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0046-8177(80)80030-X","article-title":"Immune and autoimmune aspects of diabetes mellitus.","volume":"11","author":"Handwerger","year":"1980","journal-title":"Hum Pathol"},{"issue":"6","key":"2019111808105356100_B40","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1634\/theoncologist.10-6-412","article-title":"AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.","volume":"10","author":"Cheung","year":"2005","journal-title":"Oncologist"},{"issue":"20","key":"2019111808105356100_B41","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis.","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"issue":"2","key":"2019111808105356100_B42","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ijc.24287","article-title":"Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies.","volume":"125","author":"Anderson","year":"2009","journal-title":"Int J Cancer"},{"issue":"8","key":"2019111808105356100_B43","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.","volume":"111","author":"Ekstr\u00f6m Smedby","year":"2008","journal-title":"Blood"},{"key":"2019111808105356100_B44","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.4049\/jimmunol.1002615","article-title":"Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes.","volume":"186","author":"Jagannathan-Bogdan","year":"2011","journal-title":"J Immunol"},{"issue":"3","key":"2019111808105356100_B45","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/1740774508091749","article-title":"Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements.","volume":"5","author":"Margolis","year":"2008","journal-title":"Clin Trials"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/21\/4845\/1352459\/zh802112004845.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/21\/4845\/1352459\/zh802112004845.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T08:31:55Z","timestamp":1574065915000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/21\/4845\/29936\/Increased-incidence-of-nonHodgkin-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,24]]},"references-count":45,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2012,5,24]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-06-362830","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,24]]}}}